Literature DB >> 8113478

Comparative effectiveness of social problem-solving therapy and reminiscence therapy as treatments for depression in older adults.

P A Arean1, M G Perri, A M Nezu, R L Schein, F Christopher, T X Joseph.   

Abstract

Compared the effects of 2 psychotherapies based on divergent conceptualizations of depression in later life. Seventy-five older adults diagnosed with major depressive disorder were assigned randomly to problem-solving therapy (PST), reminiscence therapy (RT), or a waiting-list control (WLC) condition. Participants in PST and RT were provided with 12 weekly sessions of group treatment. Dependent measures, taken at baseline, posttreatment, and 3-month follow-up, included self-report and observer-based assessments of depressive symptomatology. At posttreatment, both the PST and the RT conditions produced significant reductions in depressive symptoms, compared with the WLC group, and PST participants experienced significantly less depression than RT subjects. Moreover, a significantly greater proportion of participants in PST versus RT demonstrated sufficient positive change to warrant classification of their depression as improved or in remission at the posttreatment and follow-up evaluations.

Entities:  

Mesh:

Year:  1993        PMID: 8113478     DOI: 10.1037//0022-006x.61.6.1003

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  52 in total

1.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

Review 2.  Maintaining good morale in old age.

Authors:  M D Sullivan
Journal:  West J Med       Date:  1997-10

3.  The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.

Authors:  Silvia Sörensen; Katherine White; Wingyun Mak; Katherine Zanibbi; Wan Tang; Amanda O'Hearn; Mark T Hegel
Journal:  Contemp Clin Trials       Date:  2015-03-24       Impact factor: 2.226

4.  Activity scheduling as a core component of effective care management for late-life depression.

Authors:  Genevieve Riebe; Ming-Yu Fan; Jürgen Unützer; Steven Vannoy
Journal:  Int J Geriatr Psychiatry       Date:  2012-02-27       Impact factor: 3.485

Review 5.  Depression interventions among racial and ethnic minority older adults: a systematic review across 20 years.

Authors:  Dahlia Fuentes; María P Aranda
Journal:  Am J Geriatr Psychiatry       Date:  2012-11       Impact factor: 4.105

Review 6.  Depression care for the elderly: reducing barriers to evidence-based practice.

Authors:  Kathleen Ell
Journal:  Home Health Care Serv Q       Date:  2006

7.  Effects of problem solving therapy on mental health outcomes in family caregivers of persons with a new diagnosis of mild cognitive impairment or early dementia: a randomized controlled trial.

Authors:  Linda Garand; Donna E Rinaldo; Mary M Alberth; Jill Delany; Stacey L Beasock; Oscar L Lopez; Charles F Reynolds; Mary Amanda Dew
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-08       Impact factor: 4.105

8.  Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.

Authors:  Jimmy N Avari; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2014-06-20       Impact factor: 4.105

9.  Problem-Solving Therapy Reduces Suicidal Ideation In Depressed Older Adults with Executive Dysfunction.

Authors:  Kristen A Gustavson; George S Alexopoulos; Grace C Niu; Charles McCulloch; Tanya Meade; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-30       Impact factor: 4.105

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.